UA92327C2 - Застосування n-арилдіазаспіроциклічних сполук для лікування залежностей - Google Patents
Застосування n-арилдіазаспіроциклічних сполук для лікування залежностейInfo
- Publication number
- UA92327C2 UA92327C2 UAA200702904A UAA200702904A UA92327C2 UA 92327 C2 UA92327 C2 UA 92327C2 UA A200702904 A UAA200702904 A UA A200702904A UA A200702904 A UAA200702904 A UA A200702904A UA 92327 C2 UA92327 C2 UA 92327C2
- Authority
- UA
- Ukraine
- Prior art keywords
- compounds
- addiction
- effective
- significant
- effects
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4747—Quinolines; Isoquinolines spiro-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Описано спосіб лікування лікарської залежності, нікотинової залежності і/або ожиріння, що включає введення N-арилдіазаспіроциклічної сполуки або її фармацевтично прийнятної солі.Сполука ефективна для інгібування продукування й/або секреції допаміну й, отже, ефективна для пригнічення процесу фізіологічної "компенсації", що пов'язаний з усмоктуванням нікотину й/або заборонених лікарських засобів.Сполука може вводитися в ефективних кількостях для інгібування вивільнення допаміну без помітних небажаних побічних ефектів (наприклад, таких побічних ефектів, як значиме збільшення кров'яного тиску й швидкість серцебиття, значимий негативний вплив на травний тракт і значимий негативний вплив на скелетні м'язи).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60347904P | 2004-08-20 | 2004-08-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA92327C2 true UA92327C2 (uk) | 2010-10-25 |
Family
ID=35447974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200702904A UA92327C2 (uk) | 2004-08-20 | 2005-08-18 | Застосування n-арилдіазаспіроциклічних сполук для лікування залежностей |
Country Status (16)
Country | Link |
---|---|
US (1) | US20060058328A1 (uk) |
EP (1) | EP1784184A2 (uk) |
JP (1) | JP2008510711A (uk) |
KR (1) | KR20070043008A (uk) |
CN (1) | CN101022801A (uk) |
AU (1) | AU2005277410B2 (uk) |
BR (1) | BRPI0514509A (uk) |
CA (1) | CA2575461A1 (uk) |
IL (1) | IL180929A0 (uk) |
MX (1) | MX2007002045A (uk) |
NO (1) | NO20070979L (uk) |
NZ (1) | NZ552792A (uk) |
RU (1) | RU2387647C9 (uk) |
UA (1) | UA92327C2 (uk) |
WO (1) | WO2006023630A2 (uk) |
ZA (1) | ZA200701193B (uk) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE521512C2 (sv) * | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
DK1578422T3 (da) * | 2002-12-20 | 2007-07-02 | Niconovum Ab | Fysisk og kemisk stabilt nikotin-indeholdende partikelholdigt materiale |
JP5694645B2 (ja) | 2006-03-16 | 2015-04-01 | ニコノヴァム エービーNiconovum Ab | 改善された嗅ぎたばこ組成物 |
US20080247964A1 (en) * | 2006-05-08 | 2008-10-09 | Yuelian Xu | Substituted azaspiro derivatives |
WO2008096746A1 (ja) * | 2007-02-06 | 2008-08-14 | Takeda Pharmaceutical Company Limited | スピロ化合物およびその用途 |
CN101951773A (zh) * | 2008-01-15 | 2011-01-19 | 塔加西普特公司 | 7-(3-吡啶基)-1,7-二氮杂螺[4.4]壬烷的制备和对映体分离以及外消旋体和对映体的新的盐形式 |
CN102070640A (zh) * | 2009-11-24 | 2011-05-25 | 上海药明康德新药开发有限公司 | 一种1,7-二氮杂螺[4,5]壬烷及其衍生物的合成方法 |
SG185643A1 (en) * | 2010-05-27 | 2012-12-28 | Targacept Inc | Nicotinic receptor non-competitive antagonists |
CN102267995A (zh) * | 2010-06-04 | 2011-12-07 | 艾琪康医药科技(上海)有限公司 | 一种制备二氮杂螺环化合物的方法 |
CN102516146B (zh) * | 2011-11-24 | 2013-10-02 | 爱斯特(成都)生物制药有限公司 | 5位为氮的四元氮杂螺环衍生物及其制备方法和用途 |
GB201416351D0 (en) | 2014-09-16 | 2014-10-29 | Shire Internat Gmbh | Heterocyclic derivatives |
GB201416352D0 (en) | 2014-09-16 | 2014-10-29 | Shire Internat Gmbh | Spirocyclic derivatives |
RU2635105C1 (ru) * | 2016-07-15 | 2017-11-09 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Астраханский государственный университет" | Способ получения 4-арил-2,7,9-триазаспиро[4.5]декан-6,8,10-трионов |
US11299495B2 (en) * | 2016-08-01 | 2022-04-12 | Aptinyx Inc. | Spiro-lactam NMDA receptor modulators and uses thereof |
CA3181162A1 (en) | 2020-06-05 | 2021-12-09 | Stephen W. Kaldor | Inhibitors of fibroblast growth factor receptor kinases |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3282947A (en) * | 1962-05-17 | 1966-11-01 | Geschickter Fund Med Res | Unsymmetrically substituted 3, 9-diazaspiro(5, 5)undecane compounds |
US4922901A (en) * | 1988-09-08 | 1990-05-08 | R. J. Reynolds Tobacco Company | Drug delivery articles utilizing electrical energy |
DE69318854T2 (de) * | 1993-03-04 | 1998-10-08 | Pfizer | Spiroazacyclischderivate als substanz p antagonisten |
US5597919A (en) * | 1995-01-06 | 1997-01-28 | Dull; Gary M. | Pyrimidinyl or Pyridinyl alkenyl amine compounds |
US6022868A (en) * | 1995-06-29 | 2000-02-08 | Novo Nordisk Als | Substituted azacyclic or azabicyclic compounds |
US5616716A (en) * | 1996-01-06 | 1997-04-01 | Dull; Gary M. | (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds |
US5663356A (en) * | 1996-04-23 | 1997-09-02 | Ruecroft; Graham | Method for preparation of aryl substituted alefinic secondary amino compounds |
US5733912A (en) * | 1997-02-19 | 1998-03-31 | Abbott Laboratories | 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission |
DE69900220T2 (de) * | 1998-06-12 | 2002-05-08 | F. Hoffmann-La Roche Ag, Basel | Diaza-spiro[3,5]nonan-Derivate |
EP1224186B1 (en) * | 1999-10-27 | 2003-09-24 | Millennium Pharmaceuticals, Inc. | Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation |
WO2001077100A2 (en) * | 2000-04-10 | 2001-10-18 | Pfizer Products Inc. | Benzoamide piperidine compounds as substance p antagonists |
SI1519939T1 (sl) * | 2002-07-05 | 2010-04-30 | Targacept Inc | N-aril diazaspiracikliŽŤne spojine in postopki za njihovo pripravo in njihova uporaba |
-
2005
- 2005-08-18 WO PCT/US2005/029371 patent/WO2006023630A2/en active Application Filing
- 2005-08-18 UA UAA200702904A patent/UA92327C2/uk unknown
- 2005-08-18 BR BRPI0514509-0A patent/BRPI0514509A/pt not_active IP Right Cessation
- 2005-08-18 US US11/207,102 patent/US20060058328A1/en not_active Abandoned
- 2005-08-18 JP JP2007528005A patent/JP2008510711A/ja not_active Withdrawn
- 2005-08-18 MX MX2007002045A patent/MX2007002045A/es active IP Right Grant
- 2005-08-18 NZ NZ552792A patent/NZ552792A/en not_active IP Right Cessation
- 2005-08-18 CN CNA200580031767XA patent/CN101022801A/zh active Pending
- 2005-08-18 RU RU2007110020/04A patent/RU2387647C9/ru not_active IP Right Cessation
- 2005-08-18 CA CA002575461A patent/CA2575461A1/en not_active Abandoned
- 2005-08-18 AU AU2005277410A patent/AU2005277410B2/en not_active Ceased
- 2005-08-18 EP EP05786530A patent/EP1784184A2/en not_active Withdrawn
- 2005-08-18 KR KR1020077003860A patent/KR20070043008A/ko not_active Application Discontinuation
-
2007
- 2007-01-24 IL IL180929A patent/IL180929A0/en unknown
- 2007-02-09 ZA ZA200701193A patent/ZA200701193B/xx unknown
- 2007-02-21 NO NO20070979A patent/NO20070979L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MX2007002045A (es) | 2007-03-29 |
ZA200701193B (en) | 2009-09-30 |
WO2006023630A3 (en) | 2006-05-04 |
EP1784184A2 (en) | 2007-05-16 |
AU2005277410B2 (en) | 2010-06-24 |
WO2006023630A2 (en) | 2006-03-02 |
RU2387647C9 (ru) | 2011-05-27 |
IL180929A0 (en) | 2007-07-24 |
JP2008510711A (ja) | 2008-04-10 |
RU2007110020A (ru) | 2008-09-27 |
BRPI0514509A (pt) | 2008-06-10 |
AU2005277410A1 (en) | 2006-03-02 |
CN101022801A (zh) | 2007-08-22 |
KR20070043008A (ko) | 2007-04-24 |
NZ552792A (en) | 2009-12-24 |
US20060058328A1 (en) | 2006-03-16 |
NO20070979L (no) | 2007-03-19 |
RU2387647C2 (ru) | 2010-04-27 |
CA2575461A1 (en) | 2006-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA92327C2 (uk) | Застосування n-арилдіазаспіроциклічних сполук для лікування залежностей | |
NO20050012L (no) | N-aryldiazaspiracykliske forbindelser og fremgangsmater for fremstilling og anvendelse derav | |
IL295536B2 (en) | Specific tryptamines for use in the treatment of mood disorders | |
EA200800663A1 (ru) | Способ и средство профилактики и лечения нарушенного дыхания во время сна | |
MX2009012558A (es) | Combinaciones de farmacos para el tratamiento de distrofia muscular de duchenne. | |
MX2008016037A (es) | Uso de 2-aminotetralinas substituidas para la fabricacion de un medicamento para la prevencion, alivio y/o tratamiento de diversos tipos de dolor. | |
NO20050569L (no) | Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette | |
TW200616974A (en) | Chemical compounds | |
TW200635878A (en) | Hydroxybiphenylcarboxylic acids and derivatives, processes for preparing them and their use | |
EA201100305A1 (ru) | Лечение респираторных заболеваний | |
JP2011500506A5 (uk) | ||
CY1109370T1 (el) | Παραγωγα οξαδιαζολονης ως ppar δελτα αγωνιστες | |
GB2454615A (en) | Antidiabetic azabicyclo (3.1.0) hexan compounds | |
MXPA06013221A (es) | Formulaciones en polvo para la inhalacion, las cuales contienen beta-agonistas enantiomericamente puros. | |
SG140605A1 (en) | Benzothiazole derivatives | |
WO2008087461B1 (en) | Use of kynurenic acid and derivatives thereof in the treatment of conditions of the gastrointestinal tract accompanied by hypermotility and inflammation or gout or multiple sclerosis | |
EA201990419A1 (ru) | Слаборастворимый комплекс или его сольват, фармацевтическая композиция и их применение | |
MXPA05010020A (es) | Derivados de oxamida. | |
RU2016111390A (ru) | Неконкурентные антагонисты никотиновых рецепторов | |
TWI285110B (en) | Parkinson disease therapeutic agent | |
MY129832A (en) | Substituted thiophenes, processes for their preparation, their use as medicament or diagnostic and medicament comprising them | |
EA201000739A1 (ru) | Новое медицинское применение солей 3-(2,2,2-триметилгидразиниум)пропионата | |
CA2515730A1 (en) | Pyrrolidinohydrochinazolines | |
CN112209834A (zh) | 一种有机亚硝酸根供体及其制备方法与医药用途 | |
RU2014128528A (ru) | Лечение диабета I и II типа |